Skip to main content
Top
Published in: Familial Cancer 1/2018

01-01-2018 | Original Article

Constitutional mismatch repair deficiency and Lynch syndrome among consecutive Arab Bedouins with colorectal cancer in Israel

Authors: Naim Abu Freha, Yaara Leibovici Weissman, Alexander Fich, Inbal Barnes Kedar, Marisa Halpern, Ignacio Sztarkier, Doron M. Behar, Orly Arbib Sneh, Alex Vilkin, Hagit N. Baris, Rachel Gingold, Flavio Lejbkowicz, Yaron Niv, Yael Goldberg, Zohar Levi

Published in: Familial Cancer | Issue 1/2018

Login to get access

Abstract

We assessed the molecular characteristics and the frequency of mutations in mismatch-repair genes among Bedouin patients with colorectal cancer (CRC) in Israel. Bedouin patients with a diagnosis of CRC at a major hospital in the southern part of Israel were deemed eligible for this study. The primary screening method was immunohistochemical staining for mismatch-repair proteins (MLH1, MSH2, MSH6, and PMS2). For subjects with abnormal immunohistochemical staining, we performed microsatellite instability (MSI) analyses, and for tumors with a loss of MLH1 expression we also performed BRAF testing. In MSI high cases we searched further for germline mutations. Of the 24 patients enrolled, four subjects (16.7%) had MSI high tumors: one subject was found to harbor a biallelic PMS2 mutation, one subject had Lynch syndrome (LS) with MSH6 mutation and two subjects had a loss of MLH1/PMS2 proteins/BRAF wild type/normal MLH1 sequence. Ten patients (41.7%) were younger than 50 at the time of diagnosis and none had first degree relatives with CRC. In conclusion, in this cohort of 24 consecutive Arab Bedouins with CRC, one patient was found to harbor a constitutional mismatch repair deficiency, one patient had LS with MSH6 mutation, and two patients had unresolved loss of MLH1/PMS2 proteins/BRAF wild type phenotype.
Literature
1.
go back to reference Shia J (2015) Evolving approach and clinical significance of detecting DNA mismatch repair deficiency in colorectal carcinoma. Semin Diagn Pathol 32:352–361CrossRefPubMedPubMedCentral Shia J (2015) Evolving approach and clinical significance of detecting DNA mismatch repair deficiency in colorectal carcinoma. Semin Diagn Pathol 32:352–361CrossRefPubMedPubMedCentral
2.
go back to reference Giardiello FM, Allen JI, Axilbund JE et al (2014) Guidelines on Genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-society task force on colorectal cancer. Am J Gastroenterol 109:1159–1179CrossRefPubMed Giardiello FM, Allen JI, Axilbund JE et al (2014) Guidelines on Genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-society task force on colorectal cancer. Am J Gastroenterol 109:1159–1179CrossRefPubMed
3.
go back to reference Icli F, Akbulut H, Bazarbashi S et al (2010) Modification and implementation of NCCN guidelines on colon cancer in the Middle East and North Africa region. J Natl Compr Canc Netw 8(Suppl 3):S22–S25CrossRefPubMed Icli F, Akbulut H, Bazarbashi S et al (2010) Modification and implementation of NCCN guidelines on colon cancer in the Middle East and North Africa region. J Natl Compr Canc Netw 8(Suppl 3):S22–S25CrossRefPubMed
4.
go back to reference GLOBOCAN (2015) Colorectal cancer, estimated incidence, mortality and prevalence worldwide in 2012 GLOBOCAN (2015) Colorectal cancer, estimated incidence, mortality and prevalence worldwide in 2012
5.
go back to reference Rozen P, Rosner G, Liphshitz I, Barchana M (2007) The changing incidence and sites of colorectal cancer in the Israeli Arab population and their clinical implications. Int J Cancer 120:147–151CrossRefPubMed Rozen P, Rosner G, Liphshitz I, Barchana M (2007) The changing incidence and sites of colorectal cancer in the Israeli Arab population and their clinical implications. Int J Cancer 120:147–151CrossRefPubMed
6.
go back to reference Mosli MH, Al-Ahwal MS (2012) Colorectal cancer in the Kingdom of Saudi Arabia: need for screening. Asian Pac J Cancer Prev 13:3809–3813CrossRefPubMed Mosli MH, Al-Ahwal MS (2012) Colorectal cancer in the Kingdom of Saudi Arabia: need for screening. Asian Pac J Cancer Prev 13:3809–3813CrossRefPubMed
7.
go back to reference Al Quorain AA, Satti MB, Al Gindan YM, Al-Hamdan A (2000) The pattern of lower gastrointestinal disease in the eastern region of Saudi Arabia: a retrospective analysis of 1590 consecutive patients. Saudi J Gastroenterol 6:27–32PubMed Al Quorain AA, Satti MB, Al Gindan YM, Al-Hamdan A (2000) The pattern of lower gastrointestinal disease in the eastern region of Saudi Arabia: a retrospective analysis of 1590 consecutive patients. Saudi J Gastroenterol 6:27–32PubMed
8.
go back to reference Rainis T, Halloun L, Keren D et al (2010) Colorectal cancer among Arab-Israeli women-possible reasons for increased incidence and mortality. J Gastrointest Cancer 41:130–134CrossRefPubMed Rainis T, Halloun L, Keren D et al (2010) Colorectal cancer among Arab-Israeli women-possible reasons for increased incidence and mortality. J Gastrointest Cancer 41:130–134CrossRefPubMed
9.
go back to reference Olefson S, Moss SF (2015) Obesity and related risk factors in gastric cardia adenocarcinoma. Gastric Cancer 18:23–32CrossRefPubMed Olefson S, Moss SF (2015) Obesity and related risk factors in gastric cardia adenocarcinoma. Gastric Cancer 18:23–32CrossRefPubMed
10.
go back to reference Shpitz B, Millman M, Ziv Y et al (2006) Predominance of younger age, advanced stage, poorly-differentiated and mucinous histology in Israeli Arab patients with colorectal cancer. Anticancer Res 26:533–537PubMed Shpitz B, Millman M, Ziv Y et al (2006) Predominance of younger age, advanced stage, poorly-differentiated and mucinous histology in Israeli Arab patients with colorectal cancer. Anticancer Res 26:533–537PubMed
11.
12.
go back to reference Albasri A, Yosef H, Hussainy AS et al (2014) Histopathological features of colorectal cancer in Al-Madinah region of Saudi Arabia: 8 years experience. Asian Pac J Cancer Prev 15:3133–3137CrossRefPubMed Albasri A, Yosef H, Hussainy AS et al (2014) Histopathological features of colorectal cancer in Al-Madinah region of Saudi Arabia: 8 years experience. Asian Pac J Cancer Prev 15:3133–3137CrossRefPubMed
13.
go back to reference Syngal S, Brand RE, Church JM et al (2015) ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol 110:223–262CrossRefPubMedPubMedCentral Syngal S, Brand RE, Church JM et al (2015) ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol 110:223–262CrossRefPubMedPubMedCentral
14.
15.
go back to reference Vilkin A, Niv Y, Nagasaka T et al (2009) Microsatellite instability, MLH1 promoter methylation, and BRAF mutation analysis in sporadic colorectal cancers of different ethnic groups in Israel. Cancer 115:760–769CrossRefPubMedPubMedCentral Vilkin A, Niv Y, Nagasaka T et al (2009) Microsatellite instability, MLH1 promoter methylation, and BRAF mutation analysis in sporadic colorectal cancers of different ethnic groups in Israel. Cancer 115:760–769CrossRefPubMedPubMedCentral
16.
go back to reference Zahrani A, Kandil M, Badar T et al (2014) Clinico-pathological study of K-ras mutations in colorectal tumors in Saudi Arabia. Tumori 100:75–79PubMed Zahrani A, Kandil M, Badar T et al (2014) Clinico-pathological study of K-ras mutations in colorectal tumors in Saudi Arabia. Tumori 100:75–79PubMed
17.
go back to reference Goldberg Y, Barnes-Kedar I, Lerer I et al (2015) Genetic features of Lynch syndrome in the Israeli population. Clin Genet 87:549–553CrossRefPubMed Goldberg Y, Barnes-Kedar I, Lerer I et al (2015) Genetic features of Lynch syndrome in the Israeli population. Clin Genet 87:549–553CrossRefPubMed
19.
go back to reference Shia J, Stadler Z, Weiser MR et al (2011) Immunohistochemical staining for DNA mismatch repair proteins in intestinal tract carcinoma: how reliable are biopsy samples? Am J Surg Pathol 35:447–454CrossRefPubMed Shia J, Stadler Z, Weiser MR et al (2011) Immunohistochemical staining for DNA mismatch repair proteins in intestinal tract carcinoma: how reliable are biopsy samples? Am J Surg Pathol 35:447–454CrossRefPubMed
20.
go back to reference Levi Z, Kariv R, Barnes-Kedar I et al (2015) The gastrointestinal manifestation of constitutional mismatch repair deficiency syndrome: from a single adenoma to polyposis-like phenotype and early onset cancer. Clin Genet 88:474–478CrossRefPubMed Levi Z, Kariv R, Barnes-Kedar I et al (2015) The gastrointestinal manifestation of constitutional mismatch repair deficiency syndrome: from a single adenoma to polyposis-like phenotype and early onset cancer. Clin Genet 88:474–478CrossRefPubMed
21.
go back to reference Baris HN, Barnes-Kedar I, Toledano H et al (2016) Constitutional mismatch repair deficiency in Israel: high proportion of founder mutations in MMR genes and consanguinity. Pediatr Blood Cancer 63:418–427CrossRefPubMed Baris HN, Barnes-Kedar I, Toledano H et al (2016) Constitutional mismatch repair deficiency in Israel: high proportion of founder mutations in MMR genes and consanguinity. Pediatr Blood Cancer 63:418–427CrossRefPubMed
22.
go back to reference Vasen HF, Ghorbanoghli Z, Bourdeaut F et al (2014) Guidelines for surveillance of individuals with constitutional mismatch repair-deficiency proposed by the European Consortium “Care for CMMR-D” (C4CMMR-D). J Med Genet 51:283–293CrossRefPubMed Vasen HF, Ghorbanoghli Z, Bourdeaut F et al (2014) Guidelines for surveillance of individuals with constitutional mismatch repair-deficiency proposed by the European Consortium “Care for CMMR-D” (C4CMMR-D). J Med Genet 51:283–293CrossRefPubMed
23.
go back to reference Wimmer K, Kratz CP, Vasen HF et al (2014) Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium ‘care for CMMRD’ (C4CMMRD). J Med Genet 51:355–365CrossRefPubMed Wimmer K, Kratz CP, Vasen HF et al (2014) Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium ‘care for CMMRD’ (C4CMMRD). J Med Genet 51:355–365CrossRefPubMed
24.
go back to reference Durno CA, Holter S, Sherman PM, Gallinger S (2010) The gastrointestinal phenotype of germline biallelic mismatch repair gene mutations. Am J Gastroenterol 105:2449–2456CrossRefPubMed Durno CA, Holter S, Sherman PM, Gallinger S (2010) The gastrointestinal phenotype of germline biallelic mismatch repair gene mutations. Am J Gastroenterol 105:2449–2456CrossRefPubMed
25.
go back to reference Vardi-Saliternik R, Friedlander Y, Cohen T (2002) Consanguinity in a population sample of Israeli Muslim Arabs, Christian Arabs and Druze. Ann Hum Biol 29:422–431CrossRefPubMed Vardi-Saliternik R, Friedlander Y, Cohen T (2002) Consanguinity in a population sample of Israeli Muslim Arabs, Christian Arabs and Druze. Ann Hum Biol 29:422–431CrossRefPubMed
26.
go back to reference Shia J (2008) Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: Part I. The utility of immunohistochemistry. J Mol Diagn 10:293–300CrossRefPubMedPubMedCentral Shia J (2008) Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: Part I. The utility of immunohistochemistry. J Mol Diagn 10:293–300CrossRefPubMedPubMedCentral
27.
go back to reference Shia J, Tang LH, Vakiani E et al (2009) Immunohistochemistry as first-line screening for detecting colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: a 2-antibody panel may be as predictive as a 4-antibody panel. Am J Surg Pathol 33:1639–1645CrossRefPubMed Shia J, Tang LH, Vakiani E et al (2009) Immunohistochemistry as first-line screening for detecting colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: a 2-antibody panel may be as predictive as a 4-antibody panel. Am J Surg Pathol 33:1639–1645CrossRefPubMed
28.
go back to reference Shia J, Holck S, Depetris G et al (2013) Lynch syndrome-associated neoplasms: a discussion on histopathology and immunohistochemistry. Fam Cancer 12:241–260CrossRefPubMed Shia J, Holck S, Depetris G et al (2013) Lynch syndrome-associated neoplasms: a discussion on histopathology and immunohistochemistry. Fam Cancer 12:241–260CrossRefPubMed
29.
go back to reference Moreira L, Munoz J, Cuatrecasas M et al (2015) Prevalence of somatic mutl homolog 1 promoter hypermethylation in Lynch syndrome colorectal cancer. Cancer 121:1395–1404CrossRefPubMed Moreira L, Munoz J, Cuatrecasas M et al (2015) Prevalence of somatic mutl homolog 1 promoter hypermethylation in Lynch syndrome colorectal cancer. Cancer 121:1395–1404CrossRefPubMed
30.
go back to reference Carethers JM, Stoffel EM (2015) Lynch syndrome and Lynch syndrome mimics: the growing complex landscape of hereditary colon cancer. World J Gastroenterol 21:9253–9261CrossRefPubMedPubMedCentral Carethers JM, Stoffel EM (2015) Lynch syndrome and Lynch syndrome mimics: the growing complex landscape of hereditary colon cancer. World J Gastroenterol 21:9253–9261CrossRefPubMedPubMedCentral
32.
go back to reference Ladabaum U, Ford JM, Martel M, Barkun AN (2015) American gastroenterological association technical review on the diagnosis and management of Lynch syndrome. Gastroenterology 149:783–813CrossRefPubMed Ladabaum U, Ford JM, Martel M, Barkun AN (2015) American gastroenterological association technical review on the diagnosis and management of Lynch syndrome. Gastroenterology 149:783–813CrossRefPubMed
34.
go back to reference Mensenkamp AR, Vogelaar IP, van Zelst-Stams WA et al (2014) Somatic mutations in MLH1 and MSH2 are a frequent cause of mismatch-repair deficiency in Lynch syndrome-like tumors. Gastroenterology 146:643–646CrossRefPubMed Mensenkamp AR, Vogelaar IP, van Zelst-Stams WA et al (2014) Somatic mutations in MLH1 and MSH2 are a frequent cause of mismatch-repair deficiency in Lynch syndrome-like tumors. Gastroenterology 146:643–646CrossRefPubMed
35.
go back to reference Castillejo A, Vargas G, Castillejo MI et al (2014) Prevalence of germline MUTYH mutations among Lynch-like syndrome patients. Eur J Cancer 50:2241–2250CrossRefPubMed Castillejo A, Vargas G, Castillejo MI et al (2014) Prevalence of germline MUTYH mutations among Lynch-like syndrome patients. Eur J Cancer 50:2241–2250CrossRefPubMed
37.
go back to reference Tanskanen T, Gylfe AE, Katainen R et al (2015) Systematic search for rare variants in finnish early-onset colorectal cancer patients. Cancer Genet 208:35–40CrossRefPubMed Tanskanen T, Gylfe AE, Katainen R et al (2015) Systematic search for rare variants in finnish early-onset colorectal cancer patients. Cancer Genet 208:35–40CrossRefPubMed
38.
go back to reference Kilpivaara O, Aaltonen LA (2013) Diagnostic cancer genome sequencing and the contribution of germline variants. Science 339:1559–1562CrossRefPubMed Kilpivaara O, Aaltonen LA (2013) Diagnostic cancer genome sequencing and the contribution of germline variants. Science 339:1559–1562CrossRefPubMed
39.
go back to reference Glushko Y, Basher W, Barchana M, Zidan J (2010) Differences in clinical and pathological characteristics of colorectal cancer in Arab as compared to Jewish patients in Northern Israel. Fam Cancer 9:327–330CrossRefPubMed Glushko Y, Basher W, Barchana M, Zidan J (2010) Differences in clinical and pathological characteristics of colorectal cancer in Arab as compared to Jewish patients in Northern Israel. Fam Cancer 9:327–330CrossRefPubMed
40.
go back to reference Freedman LS, Barchana M, Al-Kayed S et al (2003) A comparison of population-based cancer incidence rates in Israel and Jordan. Eur J Cancer Prev 12:359–365CrossRefPubMed Freedman LS, Barchana M, Al-Kayed S et al (2003) A comparison of population-based cancer incidence rates in Israel and Jordan. Eur J Cancer Prev 12:359–365CrossRefPubMed
41.
go back to reference Kamat N, Khidhir MA, Alashari MM, Rannug U (2013) Microsatellite instability and loss of heterozygosity detected in middle-aged patients with sporadic colon cancer: a retrospective study. Oncol Lett 6:1413–1420CrossRefPubMedPubMedCentral Kamat N, Khidhir MA, Alashari MM, Rannug U (2013) Microsatellite instability and loss of heterozygosity detected in middle-aged patients with sporadic colon cancer: a retrospective study. Oncol Lett 6:1413–1420CrossRefPubMedPubMedCentral
42.
go back to reference Chen-Shtoyerman R, Theodor L, Harmati E et al (2003) Genetic analysis of familial colorectal cancer in Israeli Arabs. Hum Mutat 21:446–447CrossRefPubMed Chen-Shtoyerman R, Theodor L, Harmati E et al (2003) Genetic analysis of familial colorectal cancer in Israeli Arabs. Hum Mutat 21:446–447CrossRefPubMed
43.
go back to reference Qumseya BJ, Tayem YI, Dasa OY et al (2014) Barriers to colorectal cancer screening in Palestine: a national study in a medically underserved population. Clin Gastroenterol Hepatol 12:463–469CrossRefPubMed Qumseya BJ, Tayem YI, Dasa OY et al (2014) Barriers to colorectal cancer screening in Palestine: a national study in a medically underserved population. Clin Gastroenterol Hepatol 12:463–469CrossRefPubMed
44.
go back to reference Cohen M (2014) An integrated view of cultural perceptions of cancer among Arab people in Israel. Health Psychol Rev 8:490–508CrossRefPubMed Cohen M (2014) An integrated view of cultural perceptions of cancer among Arab people in Israel. Health Psychol Rev 8:490–508CrossRefPubMed
Metadata
Title
Constitutional mismatch repair deficiency and Lynch syndrome among consecutive Arab Bedouins with colorectal cancer in Israel
Authors
Naim Abu Freha
Yaara Leibovici Weissman
Alexander Fich
Inbal Barnes Kedar
Marisa Halpern
Ignacio Sztarkier
Doron M. Behar
Orly Arbib Sneh
Alex Vilkin
Hagit N. Baris
Rachel Gingold
Flavio Lejbkowicz
Yaron Niv
Yael Goldberg
Zohar Levi
Publication date
01-01-2018
Publisher
Springer Netherlands
Published in
Familial Cancer / Issue 1/2018
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-017-0009-7

Other articles of this Issue 1/2018

Familial Cancer 1/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine